MarkWide Research

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 310-961-4489

24/7 Customer Support

All our reports can be tailored to meet our clients’ specific requirements, including segments, key players and major regions,etc.

Global GERD Drug and Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2024-2032

Published Date: April, 2024
Base Year: 2023
Delivery Format: PDF+ Excel
Historical Year: 2017-2023
No of Pages: 263
Forecast Year: 2024-2032
SKU ebe708e29489 Category

Corporate User License

$3,450.00

The global gastroesophageal reflux disease (GERD) drug and devices market has witnessed significant growth in recent years. GERD refers to a chronic digestive disorder that causes acid reflux and heartburn. It occurs when the lower esophageal sphincter (LES) weakens or relaxes, allowing stomach acid to flow back into the esophagus. This market analysis provides valuable insights into the current trends, opportunities, and challenges in the global GERD drug and devices market.

GERD, also known as acid reflux disease, is a condition characterized by the regurgitation of stomach acid into the esophagus. It leads to symptoms such as heartburn, chest pain, difficulty swallowing, and a sour taste in the mouth. GERD can significantly impact an individual’s quality of life, and effective treatment options are essential for managing the condition.

Executive Summary:

The global GERD drug and devices market is experiencing significant growth due to the increasing prevalence of GERD worldwide. The market offers a range of pharmaceutical drugs and medical devices that help manage the symptoms of GERD effectively. With advancements in technology and a growing understanding of the disease, the market is poised for further expansion.

Global GERD Drug and Devices Market

Key Market Insights:

  • The global GERD drug and devices market is expected to witness substantial growth during the forecast period.
  • The rising prevalence of GERD, coupled with the growing aging population, is driving market growth.
  • Technological advancements in medical devices and the development of innovative drug formulations are contributing to market expansion.
  • Increasing healthcare expenditure and a focus on improving patient outcomes are fueling the demand for effective GERD treatment options.

Market Drivers:

  1. Increasing Prevalence of GERD: The prevalence of GERD is on the rise globally, primarily due to changing lifestyles, unhealthy dietary habits, and a sedentary lifestyle. This factor is driving the demand for GERD drugs and devices.
  2. Growing Aging Population: With an increase in the aging population, the incidence of GERD is also rising. Older individuals are more susceptible to developing GERD due to weakened esophageal muscles and other age-related factors.
  3. Technological Advancements in Medical Devices: Advancements in medical device technology have led to the development of innovative GERD treatment options. Minimally invasive procedures, such as laparoscopic anti-reflux surgery and endoscopic devices, have gained popularity in the market.

Market Restraints:

  1. Side Effects Associated with Medications: Some GERD medications may have side effects such as nausea, diarrhea, and headaches. These side effects can hinder patient compliance and limit the market growth to some extent.
  2. High Cost of GERD Treatments: Certain GERD treatments, such as surgical procedures, can be expensive. The high cost of these treatments may deter patients from seeking appropriate care, impacting market growth.

Market Opportunities:

  1. Increasing Awareness and Diagnosis: There is a growing awareness regarding GERD and its symptoms, leading to increased diagnosis rates. This presents an opportunity for market players to expand their reach and offer effective treatment solutions.
  2. Untapped Emerging Markets: Developing regions with a large population base, such as Asia-Pacific and Latin America, offer significant growth opportunities for the GERD drug and devices market. The rising healthcare infrastructure and increasing disposable income in these regions are expected to drive market growth.

Market Dynamics:

The global GERD drug and devices market is driven by several factors, including the rising prevalence of GERD, technological advancements in medical devices, and increasing healthcare expenditure. Additionally, changing dietary patterns, sedentary lifestyles, and the aging population contribute to the market’s growth. However, the market faces challenges related to the side effects associated with medications and the high cost of treatments. Nonetheless, the growing awareness about GERD and the untapped potential in emerging markets create promising opportunities for market players.

Regional Analysis:

The GERD drug and devices market can be analyzed based on geographical regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominates the market due to the high prevalence of GERD and the presence of key market players in the region. Europe holds a significant market share, driven by the rising aging population. Asia-Pacific is expected to witness substantial growth due to the increasing awareness about GERD and improving healthcare infrastructure.

Competitive Landscape:

The global GERD drug and devices market is highly competitive, with several prominent players operating in the market. These companies focus on research and development activities to introduce innovative treatment options. Key market players include AstraZeneca PLC, Johnson & Johnson Services, Inc., Medtronic plc, EndoGastric Solutions, Inc., and Takeda Pharmaceutical Company Limited, among others.

Segmentation:

The GERD drug and devices market can be segmented based on product type, end-user, and geography. By product type, the market includes proton pump inhibitors (PPIs), H2 receptor blockers, antacids, surgical devices, and others. End-users of GERD drugs and devices include hospitals, ambulatory surgical centers, and homecare settings.

Category-wise Insights:

  1. Pharmaceutical Drugs:
    • Proton Pump Inhibitors (PPIs): PPIs are the most commonly prescribed medications for GERD treatment. They reduce stomach acid production and provide long-lasting relief from symptoms.
    • H2 Receptor Blockers: H2 receptor blockers decrease the production of stomach acid and help alleviate GERD symptoms.
    • Antacids: Antacids neutralize stomach acid and provide temporary relief from heartburn and acid reflux.
  2. Surgical Devices:
    • Laparoscopic Anti-reflux Surgery: This minimally invasive surgical procedure strengthens the lower esophageal sphincter to prevent acid reflux.
    • Endoscopic Devices: Endoscopic procedures, such as transoral incisionless fundoplication (TIF) and radiofrequency ablation (RFA), offer non-surgical alternatives for treating GERD.

Key Benefits for Industry Participants and Stakeholders:

  1. Market Players: The GERD drug and devices market presents lucrative opportunities for pharmaceutical companies, medical device manufacturers, and healthcare providers to expand their product portfolios and increase revenue.
  2. Healthcare Professionals: Improved GERD treatment options allow healthcare professionals to offer effective care and improve patient outcomes.
  3. Patients: Access to a wide range of GERD drugs and devices provides patients with diverse treatment options, enabling them to find a suitable solution for managing their symptoms.

SWOT Analysis:

  • Strengths:
    • Increasing prevalence of GERD
    • Technological advancements in medical devices
    • Growing awareness about GERD and its symptoms
  • Weaknesses:
    • Side effects associated with medications
    • High cost of certain GERD treatments
  • Opportunities:
    • Rising aging population
    • Untapped emerging markets
  • Threats:
    • Stringent regulatory requirements
    • Competition from alternative treatment options

Market Key Trends:

  1. Shift Towards Minimally Invasive Procedures: There is a growing preference for minimally invasive surgical procedures and endoscopic treatments over traditional open surgeries. These procedures offer reduced recovery time and improved patient satisfaction.
  2. Focus on Personalized Medicine: With advancements in genetics and precision medicine, there is an increasing focus on personalized treatment approaches for GERD. Tailoring treatment plans based on individual patient characteristics can lead to better outcomes.

Covid-19 Impact:

The COVID-19 pandemic has had a mixed impact on the GERD drug and devices market. While the outbreak resulted in disruptions in the supply chain and healthcare infrastructure,leading to a temporary slowdown in the market, the increased focus on healthcare and the growing awareness about GERD have also created opportunities. The pandemic highlighted the importance of managing underlying health conditions, including GERD, and emphasized the need for effective treatment options.

Key Industry Developments:

  1. Introduction of Innovative Devices: Several companies have introduced innovative medical devices for the treatment of GERD. For example, EndoGastric Solutions, Inc. developed the Transoral Incisionless Fundoplication (TIF) procedure, which provides a minimally invasive option for GERD treatment.
  2. Collaboration and Partnerships: Key market players have entered into strategic collaborations and partnerships to enhance their product offerings and expand their market presence. These collaborations aim to combine expertise and resources to develop advanced treatment options.

Analyst Suggestions:

  1. Focus on Research and Development: Market players should invest in research and development activities to introduce innovative drugs and devices that offer improved efficacy and patient comfort.
  2. Address Unmet Needs: There is a need for more effective and affordable treatment options for GERD. Market players should identify unmet needs and develop solutions to cater to specific patient populations.

Future Outlook:

The global GERD drug and devices market is expected to witness significant growth in the coming years. The rising prevalence of GERD, increasing awareness about the disease, and technological advancements in medical devices will be key drivers for market expansion. Moreover, the development of personalized treatment approaches and the untapped potential in emerging markets present promising opportunities for market players.

Conclusion:

The global GERD drug and devices market is poised for substantial growth, driven by factors such as the increasing prevalence of GERD, growing aging population, and technological advancements in medical devices. Despite challenges related to medication side effects and high treatment costs, the market offers significant opportunities for industry participants. By focusing on innovation, collaboration, and addressing unmet needs, market players can contribute to improved GERD management and patient outcomes in the future.

Global GERD Drug and Devices Market

Segmentation Details
By Drug Type Proton Pump Inhibitors, H2 Receptor Antagonists, Others
By Device Type Anti-reflux Devices, Esophageal Stents, Others

Leading Companies in the Global GERD Drug and Devices Market:

  1. AstraZeneca plc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc.
  4. Johnson & Johnson
  5. Medtronic plc
  6. Torax Medical, Inc. (Ethicon US, LLC)
  7. EndoGastric Solutions, Inc.
  8. Boston Scientific Corporation
  9. Allergan plc
  10. Valeant Pharmaceuticals International, Inc.

North America
o US
o Canada
o Mexico

Europe
o Germany
o Italy
o France
o UK
o Spain
o Denmark
o Sweden
o Austria
o Belgium
o Finland
o Turkey
o Poland
o Russia
o Greece
o Switzerland
o Netherlands
o Norway
o Portugal
o Rest of Europe

Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Kazakhstan
o Taiwan
o Vietnam
o Thailand
o Philippines
o Singapore
o Australia
o New Zealand
o Rest of Asia Pacific

South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America

The Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Israel
o Kuwait
o Oman
o North Africa
o West Africa
o Rest of MEA

Important Questions Covered in this Study

Why Choose MWR ?

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations.

Unlimited User Access

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions.

Free Company Inclusion

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges.

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met.

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis.

Client Associated with us

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

Client Testimonials

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

error: Content is protected !!
Scroll to Top

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF
This website is safe and your personal information will be secured. Privacy Policy
Request for Discount
This website is safe and your personal information will be secured. Privacy Policy
Speak to Analyst
This website is safe and your personal information will be secured. Privacy Policy

Download Free Sample PDF